Skip to main content
OpenTrials
Completed

NCT Number: NCT06284616

JASP-1 for Children Recently Diagnosed and Their Parents

To implement and evaluate a patient-and family-centered Juvenile Arthritis Support Program during one year (JASP-1) for children recently diagnosed with JIA and their parents and after 12 months compare satistaction with care and health outcomes with a control group receiving standard care.

Completed

Looking for future studies?

Notify Me

Key information

Age range

1 year–16 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Astrid Lindgren Children´s Hospital

Stockholm, Region Stockholm, 17176, Sweden

About this study

Children diagnosed with JIA (n=50) and their parents were offered the opportunity to participate in the JASP-1 from the time of diagnosis and the following year. One year after the JIA diagnosis, the children and/or their parents were invited to answer a study-specific questionnaire comprising 16 questions. The questionnaire assessed their experiences with the information, communication, participation, and emotional support they had received during the first year with JIA. In order to compare outcomes, the questionnaire was answered by both participants in JASP-1 and patients and parents receiving standard care (n=25).

One example of a question is; If you asked questions to the health care professionals, did you get answers that you understood? Response alternatives range from "No, not at all" to "Yes, Completely" ona 5-point Likert scale.

In Swedish Pediatric Rheumatology Quality Register (PedSRQ) information about treatment, disease- and joint activity (registered by Medical doctor), and Patient Reported Outcome Measures (PROM), are measured. The total Child Health Activity Questionnaire (CHAQ-score), as well as active joints and treatment at 12 months was registered in the PedSRQ and analyzed.

The study specific questionnaire measuring patient satisfaction has been developed in collaboration with the Swedish Municipalities and County councils.

Experimental and descriptive analyses will be performed using software for statistical analysis, SPSS. Distributions of responses will be calculated in percentage. Differences in proportions between groups will be determined by performing chi-square tests.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Children 1-16 years old
  • Diagnosed with JIA at their first visit to the PRC

Exclusion criteria

  • Children that did not fulfil the criteria for JIA
  • Children/parents who could not understand the Swedish language.

Treatment and study plan

JASP-1

Behavioral

patients following the Juvenile Arthritis Support Program at the Pediatric Rheumatology Clinic

Primary outcomes

  1. Rate of Patient Reported Experienced Measures (PREM)

    Time frame: 12 months

    A study specific PREM questionnaire with 16 items. 5 point likert scale

Secondary outcomes

  1. Rate of Overall perceived health

    Time frame: 12 months

    One item on a 5 point likert scale, range from "not good at all" to "totally good"

  2. Rate of Child Health Activity Questionnaire (CHAQ)

    Time frame: 12 months

    CHAQ assesses functional ability and assists in understanding the impact of the disease on the child´s daily life. On a Visual Analog Scale (VAS) ranging 0 to 10

  3. Number of active joints

    Time frame: 12 months

    Medical doctors assessment of the childs actice joints

Sponsors and collaborators

Lead sponsor

Region Stockholm

Other Gov

Registry information

Official study title

Benefits of a Juvenile Arthritis Support Program (JASP-1) for Children Recently Diagnosed With Juvenile Idiopathic Arthritis (JIA) and Their Parents

Acronym: JASP-1

Important dates

Study start
2019
Primary completion
2023
Study completion
2023
First posted
Feb 29, 2024
Registry last updated
Mar 6, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.